Genetic Screening for Novel Regulators of Immune Checkpoint Molecules.

Genetic Screening for Novel Regulators of Immune Checkpoint Molecules.
Trends Immunol. 2020 Jun 27;:
Authors: Arens R, Scheeren FA
Abstract
Inhibitory and stimulatory immune checkpoint molecules play important roles in regulating immune responses. An increasing number of these immune regulators are currently being evaluated as targets in putative anti-cancer therapies. Recently, sophisticated genetic screens have been performed to increase our understanding of immune checkpoint pathways and their immunomodulatory regulators. Here, we summarize novel insights obtained by these screens and discuss new directions to advance possible strategies to treat malignancies.
PMID: 32605801 [PubMed - as supplied by publisher]

Source: Trends in Immunology - June 26, 2020 Category: Allergy & Immunology Authors: Arens R, Scheeren FA Tags: Trends Immunol Source Type: research